Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Patients With Chronic Liver Disease

NCT05744713 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.

NCT NCT05744713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05744713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Patients With Chronic Liver Disease
Lead sponsor
Target PharmaSolutions, Inc.
Phase
Observational
Overall status
Enrolling by invitation
Start date
February 19, 2024
Completion date
December 31, 2037
Enrollment
500,000 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic liver disease, cirrhosis